Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis

Menchén, Luis; Colón, Arturo L.; Madrigal, José L.M.; Beltrán, Luis; Botella, Sofía; Lizasoain, Ignacio; Leza, Juan C.; Moro, María A.; Menchén, Pedro; Cos, Enrique; Lorenzo, Pedro
September 2004
American Journal of Gastroenterology;Sep2004, Vol. 99 Issue 9, p1756
Academic Journal
OBJECTIVE: The present study analyzes inducible and neuronal nitric oxide synthase activity and expression in colonic mucosa of patients with ulcerative colitis, and correlates them with the progression of disease extent.METHODS: Thirty patients with ulcerative colitis were included. Synthases activity and expression were analyzed both in inflamed and noninflamed mucosa. After 2 yr, disease extent was determined and compared with extent at inclusion.RESULTS: Ca2+-independent activity, expressed as median with (interquartile range), in inflamed mucosa was higher than in noninflamed and control mucosa (102 (165–66), 24 (50–3), 1 (2.5–0.1) pmol·min−1 mg prot−1, respectively,p<0.005), whereas Ca2+-dependent activity was significantly lower in inflamed than in noninflamed and control mucosa. Western blot analysis identified inducible and neuronal isoforms and confirmed these differences. Patients with more extended disease after 2 yr had higher levels of Ca2+-independent activity in noninflamed mucosa at inclusion and lower levels of Ca2+-dependent activity than patients with persistence of similar extent of inflammation (50 (78–29)vs8 (30–0.1),p<0.005; 51 (100–36)vs150 (156–106),p<0.05, respectively). Values of Ca2+-independent activity in noninflamed mucosa greater than 30 pmol · min−1 mg prot−1 showed 80% sensitivity and 87.5% specificity in the detection of patients with subsequent progression of disease extent, whereas values of Ca2+-dependent activity in noninflamed mucosa greater than 125 pmol · min−1 mg prot−1 showed 75% sensitivity and 80% specificity in the detection of patients with stability of disease extent. A ratio of Ca2+-independent/Ca2+-dependent activities over 0.29 showed 90% sensitivity and 87.5% specificity in the detection of patients with subsequent progression of extent.CONCLUSIONS: Our results show an up-regulation of inducible nitric oxide synthase and a down-regulation of neuronal isoform not only in inflamed mucosa but also in apparently healthy mucosa of patients with ulcerative colitis. The values of activity of both isoforms in apparently healthy mucosa could predict the disease extent after 2 yr follow-up.


Related Articles

  • Clinical Trials in Ulcerative Colitis: I. Personal Observations. Korelitz, Burton I.; Margolin, Michael L. // American Journal of Gastroenterology;Mar1988, Vol. 83 Issue 3, p224 

    Focuses on the role of clinical experience in the interpretation of clinical trials in ulcerative colitis. Considerations for interpreting and utilizing the results of a clinical trial; Suggestions for clinical investigators on deciding on the design of a prospective trial; Types of controlled...

  • A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative coli. van Deventer, S. J. H.; Tami, J. A.; Wedel, M. K. // Gut;Nov2004, Vol. 53 Issue 11, p1646 

    Objective: To evaluate the safety and efficacy of an enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule, after 1, 3, and 6 months. Methods: This was a randomised, placebo controlled, double blind, escalating dose multicentre study in 40 patients with mild...

  • Cyclosporin Use in the Precolectomy Chronic Ulcerative Colitis Patient: A Community Experience and Its Relationship to Prospective and Controlled Clinical Trials. Kozarek, Richard; Bedard, Charles; Patterson, David; Justus, Peter; Sandford, Robert; Greene, Martin; Gelfand, Martin; Bredfeldt, James; Brentnall, Teri; Putnam, William; Silverman, Bruce; Brandabur, John; Hinds, John; Taubman, Gary; Wagner, Katherin; Driscoll, Richard; Mitchell, William // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2093 

    Objective: To define what effect seminal and controlled clinical trials have on practice patterns within a gastroenterological community. To define whether these practice patterns reproduce reported treatment methods and whether results comparable with those reported in such trials are noted...

  • Clinical Trials in Ulcerative Colitis: II. Historical Review. Margolin, Michael L.; Krumholz, Michael P.; Fochios, Steven E.; Korelitz, Burton I. // American Journal of Gastroenterology;Mar1988, Vol. 83 Issue 3, p227 

    Presents a review of the results of clinical trials in ulcerative colitis, as of March 1988. Application of sulfasalazine (SSZ) and its analogs in the treatment of active ulcerative colitis; Effectiveness of combining the oral and topical administration of SSZ; Comparison between the effects of...

  • Ulcerative Colitis Global Clinical Trials Review, Q2 2011.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p1138 

    The article focuses on the report "Ulcerative Colitis Global Clinical Trials Review for the second quarter of 2011," provided by the GlobalData in the U.S. It states that the report offers elemental information and data on the clinical trials of key drugs for the treatment of ulcerative colitis....

  • Using nitric oxide to treat tendinopathy. Murrell, George A. C. // British Journal of Sports Medicine;Apr2007, Vol. 41 Issue 4, p227 

    Nitric oxide (NO) is a small free radical generated by a family of enzymes, the nitric oxide synthases (NOSs). Following injury to a tendon, NO is induced by all three isoforms of NOS and NOS activity is also upregulated in tendinopathy. In animal models when NOS activity is inhibited by...

  • Topical Gels Smooth Out Tendinopathy Pain. Shrier, Ian // Physician & Sportsmedicine;Dec2004, Vol. 32 Issue 12, p10 

    The article reports on various clinical trials. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow by J.A. Paoloni, R.C. Appleyard, and J. Nelson. J.A. Paolini, R.C. Appleyard, J. Nelson's topical glyceryl trinitrate treatment of chronic noninsertional...

  • Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column. Sawada, Koji; Muto, Tetsuichiro; Shimoyama, Takashi; Satomi, Masamichi; Sawada, Toshio; Nagawa, Hirokazu; Hiwatashi, Nobio; Asakua, Hitoshi; Hibi, Toshifumi // Current Pharmaceutical Design;Feb2003, Vol. 9 Issue 4, p307 

    Background The administration of steroids is not always effective for the treatment of ulcerative colitis (UC). Their long-term use often causes adverse effects which sometimes result in their stoppage and acute exacerbation. Therefore, an alternative treatment is necessary in order to decrease...

  • Distribution of Inducible Nitric Oxide Synthase in Ulcerative Colitis. Ikeda, Ikuo; Kasajima, Takeshi; Ishiyama, Shigeru; Shimojo, Takashi; Takeo, Yasuyoshi; Nishikawa, Toshio; Kameoka, Shingo; Hiroe, Michiaki; Mitsunaga, Atsushi // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1339 

    Objective: To investigate reports that the biosynthesis of nitric oxide (NO) is increased in the colonic mucosa of patients with active ulcerative colitis (UC), which suggests that serum NOx levels may be an important indicator of UC activity. Methods: To determine the role of NO within the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics